Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5074)
All Articles published online
|
Jan 14, 2005 (publication date) through Aug 22, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Dai DJ, Lu CD, Lai RY, Guo JM, Meng H, Chen WS, Gu J. Survivin antisense compound inhibits proliferation and promotes apoptosis in liver cancer cells. World J Gastroenterol 2005; 11(2): 193-199 [PMID: 15633214 DOI: 10.3748/wjg.v11.i2.193] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i2/193.htm |
| Number | Citing Articles |
| 1 |
Mohane Selvaraj Coumar, Fang-Ying Tsai, Jagat Rakesh Kanwar, Sailu Sarvagalla, Chun Hei Antonio Cheung. Treat cancers by targeting survivin: Just a dream or future reality?. Cancer Treatment Reviews 2013; 39(7): 802 doi: 10.1016/j.ctrv.2013.02.002
|
| 2 |
Jens Bo Hansen, Niels Fisker, Majken Westergaard, Lene Sønderby Kjærulff, Henrik Frydenlund Hansen, Charlotte Albaek Thrue, Christoph Rosenbohm, Margit Wissenbach, Henrik Ørum, Troels Koch. SPC3042: a proapoptotic survivin inhibitor. Molecular Cancer Therapeutics 2008; 7(9): 2736 doi: 10.1158/1535-7163.MCT-08-0161
|
| 3 |
Yuemei Ye, Yanhui Wang, Zhaoyun Zong, Shiyu Chen. Targeting c-Myc with antisense oligonucleotides to induce apoptosis in tumor cells. Nucleosides, Nucleotides & Nucleic Acids 2025; : 1 doi: 10.1080/15257770.2025.2542835
|
| 4 |
Iori Nozaki, Natsumi Ishikawa, Yusuke Miyanari, Kazuma Ogawa, Ayako Tagawa, Sakura Yoshida, Masayuki Munekane, Kenji Mishiro, Akira Toriba, Morio Nakayama, Takeshi Fuchigami. Borealin-Derived Peptides as Survivin-Targeting Cancer Imaging and Therapeutic Agents. Bioconjugate Chemistry 2022; 33(11): 2149 doi: 10.1021/acs.bioconjchem.2c00398
|
| 5 |
Paola Turella, Giuseppe Filomeni, Maria Luisa Dupuis, Maria Rosa Ciriolo, Agnese Molinari, Francesca De Maria, Marina Tombesi, Maurizio Cianfriglia, Giorgio Federici, Giorgio Ricci, Anna Maria Caccuri. A Strong Glutathione S-Transferase Inhibitor Overcomes the P-glycoprotein-mediated Resistance in Tumor Cells. Journal of Biological Chemistry 2006; 281(33): 23725 doi: 10.1074/jbc.M604372200
|
| 6 |
Yuning Sun, Ruxian Lin, Jinming Dai, Dazhi Jin, Sheng-Qi Wang. Suppression of Tumor Growth Using Antisense Oligonucleotide Against Survivin in an Orthotopic Transplant Model of Human Hepatocellular Carcinoma in Nude Mice. Oligonucleotides 2006; 16(4): 365 doi: 10.1089/oli.2006.16.365
|
| 7 |
Rehmat Jan, Gul-e-Saba Chaudhry. Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics. Advanced Pharmaceutical Bulletin 2019; 9(2): 205 doi: 10.15171/apb.2019.024
|
| 8 |
Weipan Peng, Shenghui Li, Yating zhang, Qiuting Zhang, Wenna Li, Houyu Han, Dianming Zhou, Sheng Wang, Jin Chang, Xiaoqun Gong. A double DNAzyme-loaded MnO2 versatile nanodevice for precise cancer diagnosis and Self-Sufficient synergistic gene therapy. Chemical Engineering Journal 2022; 450: 138138 doi: 10.1016/j.cej.2022.138138
|
| 9 |
Nicolas Charette, Christine De Saeger, Valérie Lannoy, Yves Horsmans, Isabelle Leclercq, Peter Stärkel. Salirasib inhibits the growth of hepatocarcinoma cell lines in vitro and tumor growth in vivo through ras and mTOR inhibition. Molecular Cancer 2010; 9(1) doi: 10.1186/1476-4598-9-256
|
| 10 |
N Charette, C De Saeger, Y Horsmans, I Leclercq, P Stärkel. Salirasib sensitizes hepatocarcinoma cells to TRAIL-induced apoptosis through DR5 and survivin-dependent mechanisms. Cell Death & Disease 2013; 4(1): e471 doi: 10.1038/cddis.2012.200
|
| 11 |
Yalin Li, Suxiang Chen, Kamal Rahimizadeh, Zhen Zhang, Rakesh N. Veedu. Inhibition of survivin by 2′-O-methyl phosphorothioate-modified steric-blocking antisense oligonucleotides. RSC Advances 2024; 14(19): 13336 doi: 10.1039/D4RA01925C
|
| 12 |
Ragini Jenkins, Yuriy P. Bandera, Michael A. Daniele, LeAnna L. Ledford, Ashlee Tietje, Andrew A. Kelso, Michael G. Sehorn, Yanzhang Wei, Mrinmay Chakrabarti, Swapan K. Ray, Stephen H. Foulger. Sequestering survivin to functionalized nanoparticles: a strategy to enhance apoptosis in cancer cells. Biomaterials Science 2016; 4(4): 614 doi: 10.1039/C5BM00580A
|
| 13 |
Lijun Yang, Yutao Wang, Haifeng Zheng, Dong Zhang, Xiangwei Wu, Gongqin Sun, Tao Yang. Low-dose 5-fluorouracil sensitizes HepG2 cells to TRAIL through TRAIL receptor DR5 and survivin-dependent mechanisms. Journal of Chemotherapy 2017; 29(3): 179 doi: 10.1080/1120009X.2016.1277048
|
| 14 |
Safiye Aktaş, Aydanur Kargi, Nur Olgun, Gulden Diniz, Ayşe Erbay, Canan Vergin. Prognostic Significance of Cell Proliferation and Apoptosis-Regulating Proteins in Epstein-Barr Virus Positive and Negative Pediatric Hodgkin Lymphoma. Lymphatic Research and Biology 2007; 5(3): 175 doi: 10.1089/lrb.2007.5305
|
| 15 |
Anna Charalambous, Margarita Oks, Godwin Nchinda, Sayuri Yamazaki, Ralph M. Steinman. Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin. The Journal of Immunology 2006; 177(12): 8410 doi: 10.4049/jimmunol.177.12.8410
|
| 16 |
Chor-Fung Ng, Patrick Kwok-Shing Ng, Vivian Wai-Yan Lui, Jialiang Li, Judy Yuet-Wa Chan, Kwok-Pui Fung, Yuen-Keng Ng, Paul Bo-San Lai, Stephen Kwok Wing Tsui. FHL2 exhibits anti-proliferative and anti-apoptotic activities in liver cancer cells. Cancer Letters 2011; 304(2): 97 doi: 10.1016/j.canlet.2011.02.001
|
| 17 |
Samira Goldar, Mahmoud Shekari Khaniani, Sima Mansoori Derakhshan, Behzad Baradaran. Molecular Mechanisms of Apoptosis and Roles in Cancer Development and Treatment. Asian Pacific Journal of Cancer Prevention 2015; 16(6): 2129 doi: 10.7314/APJCP.2015.16.6.2129
|
| 18 |
|
| 19 |
Lijie Dong, Lulu Xie, Minjing Li, Hanhan Dai, Xia Wang, Peiyuan Wang, Qiang Zhang, Wei Liu, Xuemei Hu, Mingdong Zhao. Downregulation of B7-H4 suppresses tumor progression of hepatocellular carcinoma. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-51253-2
|
| 20 |
Theoneste Muyizere, Julien Milon Essola, Eric Nyirimigabo, Janvier Mukiza, Jean Felix Mukerabigwi. Endogenously Triggered DNAzyme‐Based Nanostructures for Gene‐Combined Therapy. Advanced NanoBiomed Research 2025; doi: 10.1002/anbr.202500044
|
| 21 |
Mengsen Li, Sheng Zhou, Xinhua Liu, Pingfeng Li, Michael A. McNutt, Gang Li. α-Fetoprotein shields hepatocellular carcinoma cells from apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand. Cancer Letters 2007; 249(2): 227 doi: 10.1016/j.canlet.2006.09.004
|
| 22 |
Weipan Peng, Shenghui Li, Yating Zhang, Qiuting Zhang, Wenna Li, Houyu Han, Dianming Zhou, Sheng Wang, Jin Chang, Xiaoqun Gong. A Double Dnazyme-Loaded Mno2 Versatile Nanodevice for Precise Cancer Diagnosis and Self-Sufficient Synergistic Gene Therapy. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4110654
|
| 23 |
Menghan Wang, Ni Zheng, Zhongchao Mai, Borong Zhou, Xinlin Yang, Miao Zhang, Wei Xia, Ying Ye. Exploration of the potential mechanism of the Fuzheng Xiegan decoction for treating hepatocellular carcinoma based on experimental and network pharmacological analyses. European Journal of Integrative Medicine 2023; 60: 102257 doi: 10.1016/j.eujim.2023.102257
|